Acute Myelocytic Leukemia

Search Trials
Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Jul 21, 2017
First Changed:
Oct 11, 2013
Disease(s):
Relapsed Acute Myeloid Leukemia
Intervention(s):
cabozantinib
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Status:
Unknown status
Last Changed:
Apr 20, 2016
First Changed:
Sep 19, 2014
Disease(s):
Antineoplastic Adverse Reaction
Intervention(s):
rhTPO
Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia
Status:
Recruiting
Last Changed:
Nov 27, 2017
First Changed:
Jun 22, 2016
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
NK Cells + Chemotherapy Starting
Role of PTK-7 in Acute Myeloid Leukemias
Status:
Completed
Last Changed:
Aug 10, 2016
First Changed:
Aug 9, 2016
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Bone marrow aspirationBlood sampling
Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Status:
Active, not recruiting
Last Changed:
May 23, 2018
First Changed:
Dec 18, 2014
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
AzacitadineFludarabineCytarabineLenograstimFilgastrim

Connect. Empower. Inspire.